banner
Microtubule/Tubulin inhibitor, Eribulin mesylate, Purity ≥98%
Inquiry

Cat. No.: X24-08-YM225

Microtubule/Tubulin inhibitor, Eribulin mesylate, Purity ≥98%

Synonym: 441045-17-6; Halichrondrin B analog; B1939; E7389; ER-086526; Halaven; (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-Amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one; methanesulfonic acid

  • CAS Number: 441045-17-6
  • Compound CID: 17755248
img
Product Size
0.5 mg; 1 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
Eribulin mesylate is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
826
Molecular Formula
C41H63NO14S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Eribulin mesylate is a cytoskeletal signaling inhibitor that plays a key role in inhibiting microtubule dynamics, leading to cell cycle arrest and apoptosis.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0